Alexandra MacLean

2023

In 2023, Alexandra MacLean earned a total compensation of $1.2M as Chief Executive Officer at AVENUE THERAPEUTICS, a 304% increase compared to previous year.

Compensation breakdown

Option Awards$800,000
Salary$400,000
Other$13,200
Total$1,213,200

MacLean received $800K in option awards, accounting for 66% of the total pay in 2023.

MacLean also received $400K in salary and $13.2K in other compensation.

Rankings

In 2023, Alexandra MacLean's compensation ranked 975th out of 2,785 executives tracked by ExecPay. In other words, MacLean earned more than 65.0% of executives.

ClassificationRankingPercentile
All
975
out of 2,785
65th
Division
Manufacturing
586
out of 1,525
62nd
Major group
Chemicals And Allied Products
404
out of 864
53rd
Industry group
Drugs
393
out of 827
53rd
Industry
Pharmaceutical Preparations
266
out of 592
55th
Source: SEC filing on May 3, 2024.

MacLean's colleagues

We found one more compensation record of an executive who worked with Alexandra MacLean at AVENUE THERAPEUTICS in 2023.

2023

David Jin

AVENUE THERAPEUTICS

Chief Financial Officer

News

In-depth

You may also like